![Lars Mecklenburg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lars Mecklenburg
Vorstandsvorsitzender bei Labcorp Early Development Services GmbH
Aktive Positionen von Lars Mecklenburg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Labcorp Early Development Services GmbH
![]() Labcorp Early Development Services GmbH Medical/Nursing ServicesHealth Services Part of Laboratory Corp. of America Holdings, Labcorp Early Development Services GmbH is a contract research organization (CRO) that provides drug development services with the goal of advancing health. The company is based in Muenster, Germany. Labcorp Early Development Services offers thousands of in vitro tests and in vivo studies in various disciplines such as toxicology, metabolism, pharmacology, pharmacometric modeling, custom antibodies, vaccine development, infusion, inhalation, ocular, as well as disease models for oncology and cardiovascular. The German company provides SEND 3.1 datasets on the same day as the final report and can customize studies based on development milestones. With facilities worldwide, Labcorp Early Development Services helps pharmaceutical and biotechnology companies reach their development milestones more quickly and efficiently. The company's mission is to improve health and improve lives. Founded in 1981, the CEOs of the company are Glenn Andrew Eisenberg, Lars Mecklenburg, and Robert Stewart Pringle. | Vorstandsvorsitzender | 27.06.2019 | - |
Karriereverlauf von Lars Mecklenburg
Ehemalige bekannte Positionen von Lars Mecklenburg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 | - |
Ausbildung von Lars Mecklenburg
University of Hannover | Doctorate Degree |
Statistik
International
Deutschland | 4 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Sektoral
Technology Services | 2 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
Labcorp Early Development Services GmbH
![]() Labcorp Early Development Services GmbH Medical/Nursing ServicesHealth Services Part of Laboratory Corp. of America Holdings, Labcorp Early Development Services GmbH is a contract research organization (CRO) that provides drug development services with the goal of advancing health. The company is based in Muenster, Germany. Labcorp Early Development Services offers thousands of in vitro tests and in vivo studies in various disciplines such as toxicology, metabolism, pharmacology, pharmacometric modeling, custom antibodies, vaccine development, infusion, inhalation, ocular, as well as disease models for oncology and cardiovascular. The German company provides SEND 3.1 datasets on the same day as the final report and can customize studies based on development milestones. With facilities worldwide, Labcorp Early Development Services helps pharmaceutical and biotechnology companies reach their development milestones more quickly and efficiently. The company's mission is to improve health and improve lives. Founded in 1981, the CEOs of the company are Glenn Andrew Eisenberg, Lars Mecklenburg, and Robert Stewart Pringle. | Health Services |
- Börse
- Insiders
- Lars Mecklenburg
- Erfahrung